exhibit 10. 1 intec pharma ltd. $ 75, 000, 000 ordinary shares sales agreement february 28, 2019 cowen and company, llc 599 lexington avenue new york, ny 10022 ladies and gentlemen : intec pharma ltd., a company organized and existing under the laws of the state of israel, public company number # # # - # # # - # # # # ( the “ company ” ), confirms its agreement ( this “ agreement ” ) with cowen and company, llc ( “ cowen ” ), as follows : 1. issuance and sale of shares. the company agrees that, from time to time during the term of this agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through cowen, acting as agent and / or principal, shares ( the “ placement shares ” ) of the company ’ s ordinary shares, no par value per share ( the “ ordinary shares ” ), having an aggregate offering price of up to $ 75, 000, 000. notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in this section 1 on the number of ordinary shares issued and sold under this agreement shall be the sole responsibility of the company, and cowen shall have no obligation in connection with such compliance. the issuance and sale of ordinary shares through cowen will be effected pursuant to the registration statement ( as defined below ) filed by the company and declared effective by the securities and exchange commission ( the “ commission ” ), although nothing in this agreement shall be construed as requiring the company to use the registration statement ( as defined below ) to issue the placement shares. the company has filed or will file, in accordance with the provisions of the securities act of 1933, as amended, and the rules and regulations thereunder ( collectively, the “ securities act ” ), with the commission a registration statement on form s - 3, including a base prospectus, relating to certain securities, including the ordinary shares, to be issued from time to time by the company, and which incorporates by reference documents that the company has filed or will file in accordance with the provisions of the securities exchange act of 1934, as amended, and the rules and regulations thereunder ( collectively, the “ exchange act ” ). the company has prepared a prospectus supplement specifically relating to the placement shares ( the “ prospectus supplement ” ) to the